Success in
Contract Manufacturing
is lead by factors such as product quality, cost competitiveness, delivery schedule and CM/Customer relationship.
In today‚s competitive environment, the contract manufacturing business is quite challenging The development of new components and technologies demands high capital investment and specialized resources. The increasing complexity of pharmaceutical products has phased out manual operating methods and forced manufacturers to utilize hi-tech automatic manufacturing techniques. This works out to be more cost-effective for them since their internal resources can be focused on more important aspects of business such as product development and marketing. This trend has led to a boom in a phenomenon called contract manufacturing (CM). The CM business in the field of pharmaceutical is growing rapidly worldwide, and is expected to further accelerate at a very robust rate over the next five years. Globally. It has been observed that production equipment being used by different manufacturers is quite similar. In manufacturing, much of the cost competitiveness comes from the manufacturing process yield. This yield can be increased through an accurate control and handling of the manufacturing equipment, careful selection of materials and their proper handling on the product line. In other words, the manufacturing process yield depends on the knowledge of the production process expertise, and how well they are able to motivate and educate production operators.
Winning Factors in Contract Manufacturing or Third Party Manufacturing
Contract manufacturing has undergone a tremendous change with the transition from through-hole to surface-mount technology. New material and new formulation techniques have been developed. Consumer awareness and global competition has made it mandatory for manufacturers to produce high-quality products at minimum cost within the delivery schedule. In addition, a thorough understanding of current manufacturing technologies is essential. Factors important for achieving success in CM are product quality, cost competitiveness, delivery schedule and CM/Customer relationship.
Product Quality
Perhaps the most important thing in contract manufacturing is to produce high-quality products. This is not a very difficult task for MK MEDICINE Modern hi-tech automatic manufacturing processes are available of manufacturing consistently high-quality products.
Cost Competitiveness
MK MEDICINE experts expect that its pharmaceutical industry will quadruple over the next 2 yr .We are using latest tunnel systems.Which is a capital intensive, quality and cost competitive ‚ process. Our mission to protect and promote public health. We fulfil our mission in several ways: -MK MEDICINE contributes to the availability of good medicinal products on national & international level by stimulating the development of innovative new medicines, by assisting pharmaceutical companies with approval procedures, by evaluating the safety, efficacy and quality of new medicines prior to authorisation and by constantly monitoring them once they are on the market.
Delivery Schedule
Time is money for us. As All Contract manufacturer demand that their products be delivered within contractual time frames. The success of a CM largely depends on whether it is capable of meeting this requirement of Customers. Maintaining a Consistent and strict delivery schedule involves close planning of the entire production. Such a planning involves; Control of incoming materials. Maintaining an operating schedule of the production line. This can be taken care of by determining the number of lines and shifts needed, the manpower required and the process yield at MK MEDICINE.
CM/Customers Relationship
MK MEDICINE In manufacturing, obtaining a better yield through controlling the process, process optimization, understanding and implementing new technologies, and providing training and motivation to the production floor personnel. Controlling the process : Process control is a tool which helps the manufacturer to run the process in such a way that results are as per the specifications. Process control is performed by:
- Determining process control limits (using the process window)
- Monitoring process results (data collection)
- Analyzing the collected data
- Implementing corrective actions, if necessary
The manufacturing process consists of a number of steps, and for each manufacturing step there are process parameters with upper and lower control limits. The desired setting of machines and their tolerance can be derived out of this measurement. It is advisable to document and describe in detail all agreed specifications and determined process parameters. This document called ‚process description‚ is an important document for controlling and optimizing the manufacturing process. After the individual process parameters have been determined and defined, the total production line needs to be set up according to the process description document.The most tangible aspect of process optimization is the balancing of cycle time of the manufacturing line. The process description also needs to be updated.
We are providing training and motivation to manufacturing personnel. Today, manufacturing equipment is very sophisticated. The person operating them should have a thorough knowledge of machines, their working principles, various parameters, the manufacturing process, materials and so on. Moreover, to use sophisticated equipments effectively, employees working on the production floor must be adequately trained. Unfortunately, some manufacturing organizations are ready to invest time and money in purchasing sophisticated equipment but not on training their personnel. It should be realized that training of the manpower is never an expenditure. It is an investment which brings quick returns. Skills and knowledge can never be acquired overnight through unorganized training, We are running many training program ideally in-house a and, if the expertise is not available, professional bodies/institutes may be contacted. The most important way to succeed in the CM (contract manufacturing) business is motivating and training the manpower. Technology and material-related issues can be resolved through a judicious use of resources, but producing quality product depends heavily on the training and motivation of people on the production floor.
Third Party or Contract-Manufacturing USP of MK Medicine
Our most of tablet and Capsule products are developed with Biocatalyst Technology. For the fast disintegration and fast absorption of the Active pharmaceutical ingredients by binding with the Beta receptors present in G.I. Tract of Humans. It helps in the 100 % absorption of the molecules and thereby increases the medicinal effect of it. It also increases the stability, removes the bad odour of the product. While the conventional; Regular product (without bio-catalyst) has the total absorption of not more than 85 - 95 % in the human body. We used Carbomer technology for Better Absorption & Dispersion in Syrups & Suspension, Nano technology for Deeper Penetration & Quicker Absorption for instant result in Skin Preparations. We develop Stable Formulations for which products are sensitive with Moisture, Light & Temperature.
Conclusion
The Contract Manufacturing business is growing at a very good pace, and MK MEDICINE is making profitable use of this opportunity. Our success as Contract Manufacturer in the field of pharmaceutical formulation depends mainly on our product quality, low production cost, on-time delivery and the CM/Customer, Client relationship. Positively, Process optimization and training of production personnel is also playing a crucial role to achieve goals of our organization.
MK MEDICINE experts expect that its pharmaceutical industry will quadruple over the next 2 yr .We are using latest tunnel systems.Which is a capital intensive, quality and cost competitive ‚ process. Our mission to protect and promote public health. We fulfil our mission in several ways: -MK MEDICINE contributes to the availability of good medicinal products on national & international level by stimulating the development of innovative new medicines, by assisting pharmaceutical companies with approval procedures, by evaluating the safety, efficacy and quality of new medicines prior to authorisation and by constantly monitoring them once they are on the market.